AHA, AARP CEOs Highlight ‘Exorbitantly-priced Drugs’ in Hill OpEd
AHA President and CEO Rick Pollack and AARP CEO Jo Ann Jenkins today authored an OpEd in The Hill discussing the skyrocketing costs of prescription drugs and what they mean for patients and our health care system. “Ultimately, the current system of exorbitantly-priced drugs is unsustainable for everyone — patients, employers, insurers, and taxpayer-funded programs like Medicare and Medicaid,” they wrote. “We stand ready to work together to find commonsense and innovative solutions that will help make drugs affordable for everyone.” Read more.
Related News Articles
Headline
The AHA’s American Society for Health Care Engineering announced July 27 that Geisinger is the winner of its 2026 Excellence in Health Care Facility Management…
Headline
The U.S. District Court for the District of Maryland July 16 enjoined eight provisions from the Centers for Medicare & Medicaid Services’ 2027 notice of…
Headline
The AHA’s American Society for Health Care Engineering will host the Health Care Facilities Innovation Conference in Minneapolis from Aug. 2-5. The conference…
Headline
The Centers for Medicare & Medicaid Services July 16 released draft guidance for the 2028 cycle of negotiations under the Medicare Drug Price Negotiation…
Headline
The inaugural Hospital Capacity Management Leadership Forum, tailored to hospital and health system leaders responsible for hospital flow, will be held July 11…
Headline
The Food and Drug Administration June 22 announced multiple actions to help accelerate early- and late-stage drug development. The actions are part of a larger…